Andrea L. Nelson - 24 Mar 2026 Form 3 Insider Report for Cigna Group (CI)

Reporting relationship
EVP, General Counsl & Corp Sec
Issuer ticker
CI
Reported as of
24 Mar 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
03 Apr 2026, 17:13:56 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Tyler Gratton, attorney-in-fact

Key filing fact

Andrea L. Nelson filed Form 3 for Cigna Group (CI) on 03 Apr 2026.

Key facts

  • This page summarizes Andrea L. Nelson's Form 3 filing for Cigna Group (CI).
  • 0 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 03 Apr 2026, 17:13.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002126614 Primary reporting owner

Nelson Andrea L

Relationship
EVP, General Counsl & Corp Sec
Address
900 COTTAGE GROVE RD., BLOOMFIELD
Signature
Tyler Gratton, attorney-in-fact
Signature date
03 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CI holding

Common Stock, $0.01 Par Value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,840
Date
24 Mar 2026
Ownership
Direct
CI holding

Common Stock, $0.01 Par Value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
72
Date
24 Mar 2026
Ownership
By 401(k)
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CI holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
24 Mar 2026
Ownership
Direct
Underlying class
Common Stock, $0.01 Par Value
Underlying amount
453
Exercise price
$227.02
Footnotes
F2
CI holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
24 Mar 2026
Ownership
Direct
Underlying class
Common Stock, $0.01 Par Value
Underlying amount
1,263
Exercise price
$294.61
Footnotes
F3
CI holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
24 Mar 2026
Ownership
Direct
Underlying class
Common Stock, $0.01 Par Value
Underlying amount
1,090
Exercise price
$336.48
Footnotes
F4
CI holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
24 Mar 2026
Ownership
Direct
Underlying class
Common Stock, $0.01 Par Value
Underlying amount
2,032
Exercise price
$305.86
Footnotes
F5
CI holding Derivative

Employee Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
24 Mar 2026
Ownership
Direct
Underlying class
Common Stock, $0.01 Par Value
Underlying amount
1,829
Exercise price
$287.55
Footnotes
F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.

Footnote F2

This option was granted on February 23, 2022. The option vested in three equal annual installments beginning March 1, 2023.

Footnote F3

This option was granted on February 22, 2023. The option vested in three equal annual installments beginning March 1, 2024.

Footnote F4

This option was granted on February 28, 2024. The option vests in three equal annual installments beginning March 1, 2025.

Footnote F5

This option was granted on February 28, 2025. The option vests in three equal annual installments beginning March 1, 2026.

Footnote F6

This option was granted on February 27, 2026. The option vests in three equal annual installments beginning March 1, 2027.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .